| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |